Effects of eicosapentaenoic acids on oxidative stress and plasma fatty acid composition in patients with lupus nephritis

In Vivo

Volumn 19, Issue 5, 2005, Pages 879-882

  Nakamura, Norio ^a   Kumasaka, Ryuichiro ^a   Osawa, Hiroshi ^a   Yamabe, Hideaki ^a   Shirato, Ken Ichi ^a   Fujita, Takeshi ^a   Murakami, Rei Ichi ^a   Shimada, Michiko ^a   Nakamura, Masayuki ^a   Okumura, Ken ^a   Hamazaki, Kei ^b   Hamazaki, Tomohito ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

8 isoprostane; Eicosapentaenoic acid (EPA); Fatty acid composition; Lupus nephritis; Oxidative stress; Systemic lupus erythematosus (SLE)

Indexed keywords

8 ISOPROSTANE; ARACHIDONIC ACID; CHOLESTEROL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOSPORIN A; DIHOMO GAMMA LINOLENIC ACID; DNA ANTIBODY; DOCOSAPENTAENOIC ACID; DOUBLE STRANDED DNA; EPADEL; FATTY ACID; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; ISOPROSTANE DERIVATIVE; LINOLEIC ACID; LIPOPROTEIN A; METHYLPREDNISOLONE; MIZORIBINE; PREDNISOLONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG PURIFICATION; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; KIDNEY BIOPSY; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; OXIDATIVE STRESS; RELIABILITY; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION; URINE LEVEL;

EID: 23044471013     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Dyerberg J: Linoleate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutr Rev 44: 125-134, 1986.
2. Prickett JD, Robinson DR and Steinberg AD: Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice. J Clin Invest 68: 556-559, 1981.
3. Clark WF, Parbtani A, Huff MW, Reid B, Holub BJ and Falardeau P: Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. Kidney Int 36: 653-660, 1989.
4. Clark WF, Parbtani A, Naylor CD, Levinton CM, Muirhead N, Spanner E, Huff MW, Philbrick DJ and Holub BJ: Fish oil in lupus nephritis: clinical findings and methodological implications. Kidney Int 44: 75-86, 1993.
5. Taysi S, Gul M, Sari RA, Akcay F and Bakan N: Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med 40: 684-688, 2002.
6. 4/5 production and fatty acid composition of plasma and leukocytes. J Clin Invest 92: 1253-1261, 1993.
7. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H and Campos E: Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 223: 53-71, 1993.
8. Takahashi M, Tsuboyama-Kasaoka N, Nakatani T, Ishii M, Tsutsumi S, Aburatani H and Ezaki O: Fish oil feeding alters liver gene expression to defend against PPAR alpha activation and ROS production. Am J Physiol Gastrointest Liver Physiol 282: G338-G348, 2002.
9. Calder PC: Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36: 1007-1024, 2001.
10. Morrow JD: The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36: 1-21, 1997.
11. Morrow JD: The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab 32: 377-385, 2000.
12. Pratico D: 172-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo. Atherosclerosis 147: 1-10, 1999.
13. Turi S, Nemeth I, Torkos A, Saghy L, Varga I, Matkovics B and Nagy J: Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22: 161-168, 1997.
14. Nakamura N, Hamazaki T, Kobayashi M, Ohta M and Okuda K: Effects of eicosapentaenoic acids on remnant-like particles cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus. In Vivo 12: 311-314, 1998.